Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Test 26 feb 123456

asdd test 123

Author Test
February 26, 2025

Nitrosamines: USFDA issues guidance on R

USFDA: Recommended Acceptable Intake Limits for Nitrosamine Drug Substance[1]Related Impurities (NDSRIs) – Guidance for Industry

Qvents
August 9, 2023